Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 22370157)

1.

Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion.

Lam HM, Suresh Babu CV, Wang J, Yuan Y, Lam YW, Ho SM, Leung YK.

Mol Cell Endocrinol. 2012 Jul 6;358(1):27-35. doi: 10.1016/j.mce.2012.02.012. Epub 2012 Feb 19.

2.

Delayed activation of extracellular-signal-regulated kinase 1/2 is involved in genistein- and equol-induced cell proliferation and estrogen-receptor-alpha-mediated transcription in MCF-7 breast cancer cells.

Liu H, Du J, Hu C, Qi H, Wang X, Wang S, Liu Q, Li Z.

J Nutr Biochem. 2010 May;21(5):390-6. doi: 10.1016/j.jnutbio.2009.01.016. Epub 2009 May 8.

PMID:
19427779
3.

Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness.

Hong J, Zhou J, Fu J, He T, Qin J, Wang L, Liao L, Xu J.

Cancer Res. 2011 Jun 1;71(11):3980-90. doi: 10.1158/0008-5472.CAN-10-2914. Epub 2011 Apr 18.

4.

COX-2 promotes breast cancer cell radioresistance via p38/MAPK-mediated cellular anti-apoptosis and invasiveness.

Lin F, Luo J, Gao W, Wu J, Shao Z, Wang Z, Meng J, Ou Z, Yang G.

Tumour Biol. 2013 Oct;34(5):2817-26. doi: 10.1007/s13277-013-0840-x. Epub 2013 Jun 15.

PMID:
23771849
5.

Yanhusuo extract inhibits metastasis of breast cancer cells by modulating mitogen-activated protein kinase signaling pathways.

Gao JL, Shi JM, He K, Zhang QW, Li SP, Lee SM, Wang YT.

Oncol Rep. 2008 Oct;20(4):819-24.

PMID:
18813823
6.

Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.

Amemiya Y, Yang W, Benatar T, Nofech-Mozes S, Yee A, Kahn H, Holloway C, Seth A.

Breast Cancer Res Treat. 2011 Apr;126(2):373-84. doi: 10.1007/s10549-010-0921-0. Epub 2010 May 13.

PMID:
20464481
7.

Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.

Mao L, Yuan L, Slakey LM, Jones FE, Burow ME, Hill SM.

Breast Cancer Res. 2010;12(6):R107. doi: 10.1186/bcr2794. Epub 2010 Dec 17.

8.

Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.

Chun J, Kim YS.

Chem Biol Interact. 2013 Oct 5;205(3):212-21. doi: 10.1016/j.cbi.2013.07.002. Epub 2013 Jul 16.

PMID:
23867902
9.

Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line.

Pontillo CA, García MA, Peña D, Cocca C, Chiappini F, Alvarez L, Kleiman de Pisarev D, Randi AS.

Toxicol Sci. 2011 Apr;120(2):284-96. doi: 10.1093/toxsci/kfq390. Epub 2010 Dec 30.

10.

Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4.

Ketolainen JM, Alarmo EL, Tuominen VJ, Kallioniemi A.

Breast Cancer Res Treat. 2010 Nov;124(2):377-86. doi: 10.1007/s10549-010-0808-0. Epub 2010 Feb 25.

PMID:
20182795
11.

High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells.

Pan B, Ren H, Ma Y, Liu D, Yu B, Ji L, Pan L, Li J, Yang L, Lv X, Shen X, Chen B, Zhang Y, Willard B, He Y, Zheng L.

Int J Cancer. 2012 Jul 1;131(1):70-82. doi: 10.1002/ijc.26341. Epub 2011 Aug 30.

PMID:
21805479
13.
14.
15.

Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.

Du J, Wang XF, Zhou QM, Zhang TL, Lu YY, Zhang H, Su SB.

Oncol Rep. 2013 Aug;30(2):685-94. doi: 10.3892/or.2013.2498. Epub 2013 May 27.

PMID:
23708383
16.
18.

Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.

Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu K, Luan J, Duan H, Lu Z, Wang F, Wu E, Yagasaki K, Zhang G.

Mol Cancer. 2009 Oct 1;8:81. doi: 10.1186/1476-4598-8-81.

19.

Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.

Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D.

Breast Cancer Res. 2012 Feb 21;14(1):R35.

20.

A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.

Zhan Y, Zhang Y, Liu C, Zhang J, Smith WW, Wang N, Chen Y, Zheng L, He L.

Cancer Prev Res (Phila). 2012 Jun;5(6):864-73. doi: 10.1158/1940-6207.CAPR-11-0575. Epub 2012 Apr 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk